22.11.2014 Views

African Traditional Herbal Research Clinic THE ... - Blackherbals.com

African Traditional Herbal Research Clinic THE ... - Blackherbals.com

African Traditional Herbal Research Clinic THE ... - Blackherbals.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Continued from page 19- Burkina Faso: Meningitis<br />

Epidemics in Vaccinated Areas<br />

been immunized.<br />

"[Health researchers] are currently collecting information<br />

so as to identify the factors explaining the recurrence of<br />

the epidemic in districts where populations have been<br />

vaccinated", Ousmane Badolo, head of the epidemiologic<br />

surveillance department at the ministry of health, told<br />

IRIN.<br />

Vaccination campaigns target people between 2 to 30<br />

years old; according to the ministry of health, 80 to 90<br />

percent of the victims of meningitis belong to that age<br />

group.<br />

A total of 714 people have died since 1 January out of<br />

7,184 cases.<br />

Several different bacteria can cause meningitis which is<br />

an inflammation of the protective membranes covering<br />

the central nervous system. The Neisseria sero-group is<br />

one of the most important to watch because it often leads<br />

to epidemics, experts say.<br />

Badolo, the epidemiologist, said that health research<br />

teams from the UN World Health Organization and USbased<br />

Centers for Disease Control and Prevention have<br />

<strong>com</strong>e to Burkina Faso to investigate. "This is the first<br />

time that such research is being conducted," Badolo said,<br />

adding that at this stage he could only guess why the<br />

vaccination programmes have not worked.<br />

"Perhaps it is because of population M displacement," he<br />

said, "for instance in gold mining areas people are often<br />

<strong>com</strong>ing and going."<br />

The health researchers will focus their work on the<br />

districts of Réo in the central west of the country, Boulsa<br />

in the central north, Titao in the north and in Sig-nonghin<br />

a district in the north of the capital Ouagadougou.<br />

The populations in each of those four districts were<br />

vaccinated last year yet each has reached epidemic<br />

thresholds.<br />

A total of five out of the country's 55 districts have<br />

reached the epidemic threshold and 14 others are on alert.<br />

Meanwhile, 3.5 million people have been vaccinated this<br />

year out of a population of 14 million. The government<br />

said it is in the process of procuring a million more<br />

vaccines with the help of UN Children's Agency<br />

UNICEF.<br />

[This report does not necessarily reflect the views of the<br />

United Nations ]<br />

http://allafrica.<strong>com</strong>/stories/200804110048.html<br />

☻☻☻☻☻☻<br />

Africa: New Meningitis<br />

Vaccine Nears Debut<br />

12 March 2009<br />

Dakar — A new vaccine that promises to eradicate<br />

meningitis in Africa will be rolled out in a mass<br />

campaign in West Africa this year, according to the UN<br />

World Health Organization (WHO).<br />

Twenty-five million doses of the meningococcal A, or<br />

MenA, vaccine are currently in production in India and<br />

the drug is expected to be introduced in Burkina Faso late<br />

2009.<br />

"This is the beginning of the end of the disease," said<br />

Mark LaForce, the director of the Meningitis Vaccine<br />

Project (MVP), an initiative of WHO and the non-profit<br />

PATH that has been developing the vaccine since 2003.<br />

The vaccine currently used in the region spanning from<br />

Senegal to Ethiopia - called the 'meningitis belt' for its<br />

vulnerability to deadly outbreaks - offers at most two<br />

years of protection, according to MVP.<br />

While the disease is more deadly in the meningitis belt<br />

than anywhere else in the world, there have been no<br />

prevention vaccines for the strain found in Africa- until<br />

now, according to clinical trials with MenA.<br />

Recent studies with patients age one to 29 in India, Mali,<br />

and The Gambia have shown that the new vaccine will<br />

provide long-term protection. Lead researcher LaForce<br />

has said the drug "will allow the elimination of the<br />

meningococcal [meningitis] epidemics that have afflicted<br />

the continent [Africa] for more than 100 years."<br />

Months away from the vaccine's US$29-million donorfinanced<br />

debut in three countries - Burkina Faso, Mali<br />

and Niger - LaForce told IRIN the deadly bacteria that<br />

attack the spinal cord and brain lining cannot be wiped<br />

out overnight.<br />

"Look at polio and how long it took to eradicate that. We<br />

are looking at 10 years at least [for eradication]," he said.<br />

More than 45 years after the polio vaccine was licensed,<br />

there were still more than 1,600 infections worldwide in<br />

2008, according to WHO - down from 350,000 cases 20<br />

years ago.<br />

LaForce told IRIN the MenA vaccination campaign's<br />

goal is to reach "herd immunity", in which if at least 70<br />

percent of the population is immunised, then the entire<br />

population is protected.<br />

When asked if people who might refuse vaccinations<br />

could thwart herd immunity, LaForce said the response<br />

Continued on page 21<br />

-20- <strong>Traditional</strong> <strong>African</strong> <strong>Clinic</strong> April 2009

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!